Related Experiment Video
Updated: Jul 6, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and
Francesca Finetti1, Michela Pellegrini, Cristina Ulivieri
1Department of Evolutionary Biology, University of Siena, Siena, Italy.
Abstract:
The ShcA locus encodes 3 protein isoforms that differ in tissue specificity, subcellular localization, and function. Among these, p66Shc inhibits TCR coupling to the Ras/MAPK pathway and primes T cells to undergo apoptotic death. We have investigated the outcome of p66Shc deficiency on lymphocyte development and homeostasis. We show that p66Shc(-/-) mice develop an age-related lupus-like autoimmune disease characterized by spontaneous peripheral T- and B-cell activation and proliferation, autoantibody production, and immune complex deposition in kidney and skin, resulting in autoimmune glomerulonephritis and alopecia. p66Shc(-/-) lymphocytes display enhanced proliferation in response to antigen receptor engagement in vitro and more robust immune responses both to vaccination and to allergen sensitization in vivo. The data identify p66Shc as a negative regulator of lymphocyte activation and show that loss of this protein results in breaking of immunologic tolerance and development of systemic autoimmunity.
Insights
Mice lacking p66Shc protein develop a lupus-like autoimmune disease due to uncontrolled lymphocyte activation. This study reveals p66Shc as a key regulator of immune tolerance, crucial for preventing autoimmunity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The ShcA locus produces three protein isoforms, including p66Shc, which regulates T-cell receptor (TCR) signaling and apoptosis.
- p66Shc plays a role in T-cell activation and programmed cell death.
Purpose of the Study:
- To investigate the effects of p66Shc deficiency on lymphocyte development and immune homeostasis.
- To determine the role of p66Shc in regulating immune tolerance and preventing autoimmune diseases.
Main Methods:
- Studied p66Shc knockout (p66Shc(-/-)) mice to assess lymphocyte development and autoimmune phenotypes.
- Analyzed lymphocyte activation, proliferation, autoantibody production, and immune complex deposition in p66Shc(-/-) mice.
- Evaluated immune responses in p66Shc(-/-) mice following vaccination and allergen sensitization.
Main Results:
- p66Shc(-/-) mice spontaneously develop an age-related lupus-like autoimmune disease.
- Characterized by peripheral T- and B-cell activation, autoantibody production, and immune complex deposition leading to glomerulonephritis and alopecia.
- p66Shc(-/-) lymphocytes exhibit enhanced proliferation upon antigen receptor engagement and stronger immune responses in vivo.
Conclusions:
- p66Shc acts as a negative regulator of lymphocyte activation.
- Loss of p66Shc function leads to the breakdown of immunologic tolerance.
- p66Shc deficiency results in the development of systemic autoimmunity.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

